Blood Flow Restriction Therapy on Bone and Lean Mass After ACL Reconstruction .
Blood Flow Restriction Therapy Preserves Lower Extremity Bone and Muscle Mass After ACL Reconstruction
Sports Health. 2022 Jun 27;19417381221101006.Thirty-two patients undergoing anterior cruciate ligament reconstruction were randomized to receive blood flow restriction therapy in combination with low-load resistance (n=17) or standard rehabilitation (n=15). The primary outcome of this trial was to determine changes in bone and muscle mass from presurgery to 6 and 12 weeks post-operatively. Secondary outcomes such as knee function (single leg squats, eccentric step-downs, balance, leg press, and hamstring curls) were recorded at 8 and 12 weeks post-operatively. Significant differences in bone and muscle mass were apparent at 6 and 12 weeks with regard to the whole limb with better results in the restriction group. Better bone mass femur outcomes were apparent in the blood flow restriction group at 12 weeks and lean mass outcomes at both 6 and 12 weeks in the thigh.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics